Stock GABA GABATHER AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Gabather AB

Equities

GABA

SE0010869552

Biotechnology & Medical Research

Delayed Nasdaq Stockholm
Other stock markets
 17:00:00 25/06/2024 BST 		5-day change 1st Jan Change
1.545 SEK -0.96% Intraday chart for Gabather AB -3.44% +9.57%
05-30 Gabather AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Gabather AB Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct A Clinical Phase II Study with GT-002 CI

Business Summary

Gabather AB is a Sweden-based company engaged pharmaceutical industry. The Company develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The Company mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.

Number of employees: 3

Managers

Managers TitleAgeSince
Michael Robin Witt CEO
 Chief Executive Officer - 31/08/14
Kristofer Svensson DFI
 Director of Finance/CFO - -
Christine Natasha Ryan COO
 Chief Operating Officer - -
Stefan Rehnmark CTO
 Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Michael Robin Witt CEO
 Chief Executive Officer - 31/08/14
Bert Roland Kari Junno FOU
 Founder 58 02/11/14
Anders Lönnberg CHM
 Chairman - 31/12/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,095,681 14,036,677 ( 77.57 %) 0 77.57 %

Company contact information

Gabather AB

Forskargatan 20J Byggn 215 N

151 36, Södertälje

+46 7 36 87 28 39

http://www.gabather.com
address Gabather AB(GABA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
GABATHER AB Stock Gabather AB
+9.57% 2.77M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+16.45% 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+21.96% 116B
ARGENX SE Stock argenx SE
+23.87% 27.03B
BIONTECH SE Stock BioNTech SE
-20.05% 20.36B
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.28% 15.91B
GENMAB A/S Stock Genmab A/S
-16.52% 16.43B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.35% 15.6B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+63.91% 14.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.52% 13.59B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. GABA Stock
  4. Company Gabather AB